RYR2 mutation in non‐small cell lung cancer prolongs survival via down‐regulation of DKK1 and up‐regulation of GS1‐115G20.1: A weighted gene Co‐expression network analysis and risk prognostic models

RYR2 mutation is clinically frequent in non‐small cell lung cancer (NSCLC) with its function being elusive. We downloaded lung squamous cell carcinoma and lung adenocarcinoma samples from the TCGA database, split the samples into RYR2 mutant group (n = 337) and RYR2 wild group (n = 634), and establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Wenjun, Li, Yongwu, Chen, Xi, Hu, Sheng, Cheng, Wanli, Cao, Yu, Gao, Jingcheng, Chen, Xia, Xiong, Da, Li, Hongrong, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965387/
https://www.ncbi.nlm.nih.gov/pubmed/34877784
http://dx.doi.org/10.1049/syb2.12038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965387/
https://www.ncbi.nlm.nih.gov/pubmed/34877784
http://dx.doi.org/10.1049/syb2.12038

Ejemplares similares